A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.

Also called NCT01977573

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 252 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01977573
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada, Czechia, Denmark, France, Germany, Hungary, Japan, Poland, Russia, South Korea, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01977573. Randomized; single masking; primary purpose treatment. Start 2013-10-31 (registry gives no type); primary completion 2015-05-01 (actual). Results posted on 2016-06-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
Condition
Anaemia
Intervention (Drug)
GSK1278863
Intervention (Drug)
rhEPO
Lead sponsor
GlaxoSmithKline (class: industry)

Record details

Record id
cardio:ct-nct01977573
Content hash
6634dc5139d2ea3b4cfb53e80740b4a16def11739b43b2764ad87f967c294e48